The purpose of the Clinical Trials Support Unit (CTSU) is to provide a central Cancer Center resource tocoordinate and assist with all cancer-related clinical research within the affiliated hospitals and ambulatorycare centers of BCM. It will foster the establishment and maintenance of clinical trial related infrastructure,especially for investigators and institutions with less prior experience and knowledge in this area. By thismechanism, it will enable and increase clinical trial enrollment to a wide spectrum of cancer-related studies.The Unit's efforts will particularly target hospitals and institutions with a higher proportion of minority andeconomically disadvantaged patients, providing greater access to participation in clinical research for thesepopulations. In addition the CTSU will facilitate liaison with external co-investigators and cooperative groups,federal agencies, and the pharmaceutical industry.The CTSU will provide three major services to Cancer Center investigators:1) Assistance with regulatory and administrative matters relating to clinical research and trials includingIRB compliance and approval, ongoing amendments and renewal, external agency compliance (suchas the FDA), maintenance of regulatory files, and assistance with internal and external audits;2) Provision of research nursing/clinical trials management especially to less experienced investigatorsor those with limited programs;3) Provision of data management and bioinformatics expertise including database instruction andmaintenance and internal audits.The CTSU will thus provide efficient, cost-effective support to aid Cancer Center investigators in the conductof scientifically valuable cancer clinical trials and will improve access to these trials, especially forunderserved minorities. The main offices of the CTSU are located within the Cancer Center administrativeoffices on the fourth floor of the Cullen Bldg at Baylor College of Medicine. Satellite offices for ResearchNursing/Research Coordinators are located in each of the College's major affiliated clinical facilities includingthe Baylor Ambulatory Care Clinic, St. Luke's Episcopal Hospital, Texas Children's Hospital, the Ben TaubGeneral Hospital, and the Michael E. DeBakey VA Medical Center. The Resource Leader is Martha Mims,M.D./Ph.D.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
1P30CA125123-01
Application #
7514693
Study Section
Subcommittee G - Education (NCI)
Project Start
2007-07-01
Project End
2010-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
1
Fiscal Year
2007
Total Cost
$102,504
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Kundu, Samrat T; Grzeskowiak, Caitlin L; Fradette, Jared J et al. (2018) TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins. Nat Commun 9:2731
Kim, Myunghoo; Galan, Carolina; Hill, Andrea A et al. (2018) Critical Role for the Microbiota in CX3CR1+ Intestinal Mononuclear Phagocyte Regulation of Intestinal T Cell Responses. Immunity 49:151-163.e5
Mamonkin, Maksim; Mukherjee, Malini; Srinivasan, Madhuwanti et al. (2018) Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies. Cancer Immunol Res 6:47-58
Morriss, Ginny R; Rajapakshe, Kimal; Huang, Shixia et al. (2018) Mechanisms of skeletal muscle wasting in a mouse model for myotonic dystrophy type 1. Hum Mol Genet 27:2789-2804
Lanza, Denise G; Gaspero, Angelina; Lorenzo, Isabel et al. (2018) Comparative analysis of single-stranded DNA donors to generate conditional null mouse alleles. BMC Biol 16:69
Jeong, Mira; Park, Hyun Jung; Celik, Hamza et al. (2018) Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo. Cell Rep 23:1-10
Boudreaux, Seth P; Duren, Ryan P; Call, Steven G et al. (2018) Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia. Leukemia :
Sukumaran, Sujita; Watanabe, Norihiro; Bajgain, Pradip et al. (2018) Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment. Cancer Discov 8:972-987
Kaochar, Salma; Mitsiades, Nicholas (2018) A Novel Mechanism to Drive Castration-Resistant Prostate Cancer. Trends Endocrinol Metab 29:366-368
Johnston, A N; Bu, W; Hein, S et al. (2018) Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions. Breast Cancer Res 20:42

Showing the most recent 10 out of 991 publications